Features of pharmacotherapy for gastroesophageal reflux disease in pregnant women

Journal Title: Гастроентерологія - Year 2019, Vol 53, Issue 3

Abstract

The article deals with the problem of gastroesophageal reflux disease in pregnant women. The peculiarities of the mechanism of developing this disease in pregnant women are highlighted. A number of scientific studies of different authors on the safety of therapeutic measures in this category of patients have been analyzed. The author focuses on the presence of unresolved issues in pharmacotherapy for gastroesophageal reflux disease in pregnant women.

Authors and Affiliations

Yu. S. Breslavets

Keywords

Related Articles

Features of Pancreatic Pathology in Children

Background. The prevalence of pancreatitis in children with digestive disorders is 5–25 %. Aim of research: to determine the prevalence of pancreatic pathology in children. Material and methods. The research was conducte...

Comparative prevalence and features of the course of ulcerative colitis in countries of the same geographical meridian: Ukraine-Tunisia. Testing the North-South hypothesis

Background. Chronic inflammatory bowel diseases (ulcerative colitis (UC) and Crohn’s disease) are severe, incu­rable illnesses accompanied by loss of work ability and early death due to their complications in most cases....

Histometric Features of Endocrine Islets of the Pancreas in Chronic Pancreatitis

Long-existing chronic pancreatitis (CP) in the last stages of development leads to the destruction of the endocrine pancreatic tissue, but the mechanisms of these changes are not well understood. The aim of the study was...

Chronic atrophic gastritis: risk factors and their correlation with morphological changes of gastric mucosa

Background. Chronic atrophic gastritis (CAG) is the pre-cancer diseases of stomach. There are often intestinal metaplasia and dysplasia, which could lead to gastric cancer development. The purpose was to study the differ...

Evaluating the Effectiveness of Essential Phospholipids in Patients with Chronic Viral Hepatitis C

The study evaluated the effectiveness of essential phospholipids in patients with chronic viral hepatitis C. A positive dynamics of clinical symptoms, liver function tests, lipid metabolism and elastography data has been...

Download PDF file
  • EP ID EP668165
  • DOI 10.22141/2308-2097.53.3.2019.181472
  • Views 85
  • Downloads 0

How To Cite

Yu. S. Breslavets (2019). Features of pharmacotherapy for gastroesophageal reflux disease in pregnant women. Гастроентерологія, 53(3), 196-202. https://europub.co.uk/articles/-A-668165